{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:32:47Z","timestamp":1767853967800,"version":"3.49.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T00:00:00Z","timestamp":1149724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>To determine whether corporal veno\u2010occlusive dysfunction (CVOD), corporal smooth muscle (SM) loss, fibrosis and oxidative stress occur in a rat model of type 2 diabetes, and whether these are counteracted by pioglitazone, as pioglitazone is vasculoprotective, and corporal SM is an extension of arterial SM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>\n                      Male obese Zucker\n                      <jats:italic>fa\/fa<\/jats:italic>\n                      rats were fed chow containing 0%, 0.001% or 0.02% pioglitazone for 2 or 5\u2003months, using untreated lean Zucker and Fischer 344 rats as controls. Functional changes were determined by dynamic\u2010infusion cavernosometry. Histological changes were assessed by histochemistry and immunohistochemistry followed by quantitative image analysis and\/or quantitative Western blot.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>CVOD was detected at 4.5\u2003months of diabetes, accompanied by a lower corporal SM\/collagen ratio, and increases in collagen, collagen III\/I ratio, apoptotic index, and systemic and tissue oxidative stress. In the short\u2010term treatment, high\u2010dose pioglitazone normalized glycaemia and ameliorated fibrosis and oxidative stress, but induced CVOD, whereas the effects with the low dose were not significant. However, low\u2010dose pioglitazone for 5\u2003months corrected all alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      Type 2 diabetes in Zucker\n                      <jats:italic>fa\/fa<\/jats:italic>\n                      rats was associated with penile corporal fibrosis, oxidative stress, and CVOD, which were ameliorated by long\u2010term low\u2010dose pioglitazone, suggesting that this drug might protect the SM, independently from its antidiabetic effect.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2006.06268.x","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T13:33:44Z","timestamp":1149773624000},"page":"116-124","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Pioglitazone prevents corporal veno\u2010occlusive dysfunction in a rat model of type 2 diabetes mellitus"],"prefix":"10.1111","volume":"98","author":[{"given":"ISTVAN","family":"KOVANECZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MONICA G.","family":"FERRINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DOLORES","family":"VERNET","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GABY","family":"NOLAZCO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JACOB","family":"RAJFER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NESTOR F.","family":"GONZALEZ\u2010CADAVID","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,8]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1185\/0300799009117035"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042307-200411000-00012"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.4065\/77.3.276"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000075361.35942.17"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2003.12.006"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568006043481347"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.07.012"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.2003.tb02686.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66200-1"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.03.039"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001693"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.1998.tb00599.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900792"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198904203201601"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.11.034"},{"key":"e_1_2_8_17_2","first-page":"H1960","article-title":"Diminished neurogenic but not pharmacological erections in the 2\u2010 to 3\u2010month experimentally diabetic F\u2010344 rat","volume":"272","author":"Rehman J","year":"1997","journal-title":"Am J Physiol"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.00065.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.136.12.7588327"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.1_Suppl.I110"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.08.003"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00134.2005"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-002-0024-4"},{"key":"e_1_2_8_24_2","first-page":"69","article-title":"Transforming growth factor\u2010beta: a key mediator of fibrosis","volume":"117","author":"Mauviel A","year":"2005","journal-title":"Methods Mol Med"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpuro0201"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/S0270-9295(03)00132-3"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570161054368643"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.2004.tb02862.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566524053766068"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200505030-00006"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347546"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01312.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.05955.x"},{"key":"e_1_2_8_34_2","doi-asserted-by":"crossref","unstructured":"FerriniMG NolazcoG VernetD Gonzalez\u2010CadavidNF BermanJ.Increased vaginal oxidative stress apoptosis and inducible nitric oxide synthase in a diabetic rat. model: implications for vaginal fibrosis.Fertil Steril2005; in press","DOI":"10.1016\/j.fertnstert.2006.01.058"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.104.030833"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1006\/niox.2001.0421"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2003.12.002"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01241.x"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.04.001"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1358\/dnp.2004.17.4.829049"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2006.06268.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2006.06268.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:34:52Z","timestamp":1761752092000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2006.06268.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1111\/j.1464-410X.2006.06268.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2006.06268.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,8]]},"assertion":[{"value":"2006-06-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}